Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases. A crucial step toward their successful clinical application is to examine the immune response that might be launched against them after transplantation. We used two experimental platforms to examine the in vivo leukocyte response toward hESCs. First, immunocompetent and immunodeficient mouse strains were used to identify T cells as the major component that causes xenorejection of hESCs. Second, mice that were conditioned to carry peripheral blood leukocytes from human origin were used to test the human leukocyte alloresponse toward undifferentiated and differentiated hESCs. Using this model, we have detected only a minute immune response toward undifferentiated as well as differentiated hESCs over the course of 1 month, although control adult grafts were repeatedly infiltrated with lymphocytes and destroyed. Our data show that the cells evade immune destruction due to a low immunostimulatory potential. Nevertheless, a human cytotoxic T lymphocyte clone that was specifically prepared to recognize two hESC lines could lyse the cells after major histocompatibility complex class I (MHC-I) induction. Although MHC-I levels in hESCs are sufficient for rejection by cytotoxic T cells, our data suggest that the immunostimulatory capacity of the cells is very low. Thus, immunosuppressive regimens for hESC-based therapeutics could be highly reduced compared with conventional organ transplantation because direct allorejection processes of hESCs and their derivatives are considerably weaker.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although most of the pluripotent stem cells have low HLA expression [93], iPSC derivatives can trigger an immune response.”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [93]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
In vitro differentiation of transplantable neural precursors from human embryonic stem cells
Zhang, S.-C., Wernig, M., Duncan, I. D., Brüstle, O., & Thomson, J. A. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1129 · Cited by 1,912
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., & Benvenisty, N. (2000) · Molecular Medicine · doi:10.1007/bf03401776 · Cited by 1,500
Self-citationPrognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D. A., & Benvenisty, N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11307 · Cited by 1,134
Self-citationNeural progenitors from human embryonic stem cells
Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., & Ben-Hur, T. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1134 · Cited by 1,119
Cited by
Items 301–400 of 403
Kim, E., Miyake, B., Aggarwal, M., Voetlause, R., Griffith, M., & Zavazava, N. (2014) · Immunology · doi:10.1111/imm.12268 · Cited by 3
Immune roles of dendritic cells in stem cell transplantation
Zhang, C., Liao, W., Liu, F., Zhu, X., He, X., & Hu, A. (2017) · Clinical Transplantation · doi:10.1111/ctr.13090 · Cited by 3
A hypothetical trivalent epigenetic code that affects the nature of human ESCs
Ishikawa, Y., & Nakai, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238742 · Cited by 3
“Previous studies suggested that ESCs show lower susceptibility to immune rejection and have diminished immunogenicity compared with differentiated tissues [22, 23].”
BackgroundEvolution of Stem Cells in Cardio-Regenerative Therapy
Fakoya, A. O. J., Fenemigho, I., Asuzu, C. V., Ukponmwan, E. E., Nnawuba, K. C., & Haider, K. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-77052-5_7 · Cited by 3
Meet the inlaws: Embryonic stem cell derivatives meet the immune system
Tabayoyong, W., & Zavazava, N. (2009) · Cell Research · doi:10.1038/cr.2009.38 · Cited by 3
Transplantation of mouse embryonic stem cells induces hematopoietic and tissue chimerism in rats
Baertschiger, R. M., Gonelle‐Gispert, C., Morel, P., Sgroi, A., Serre‐Beinier, V., Stouffs, M., Jaconi, M. E., & Bühler, L. H. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00603.x · Cited by 3
Prospects for Designing ‘Universal’ Stem Cell Lines
CICCIARELLI, J. C., Lemp, N. A., & Kasahara, N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5480-9_9 · Cited by 3
The role of tissue adaptation and graft size in immune tolerance
Hauben, E., Roncarolo, M. G., Draghici, E., & Nevo, U. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.05.006 · Cited by 3
“Differences between groups were assessed using repeated measures ANOVA and 2-tailed t-test.”
MethodCardiomyocytes from embryonic stem cells: towards human therapy
Földes, G., Harding, S. E., & Ali, N. N. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.10.1473 · Cited by 8
“2 Immunogenicity Because of their early stage of development, undifferentiated ESC were considered to have immune-privileged characteristics [106], partly owing to the discrete expression levels of HLA class I antigens [107], and hence may survive after allogenic transplantation without the need for immunosuppression.”
BackgroundCubillo, E. J., Ngo, S. M., Juarez, A., Gagan, J., Lopez, G. D., & Stout, D. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2017.3.191 · Cited by 3
“In addition, there is also the hurdle of immune rejection by the recipient‟s immune system; however, there are studies indicating ESCs and ES cell-derived NSCs display characteristics of immunotolerance [75,80,81].”
Construction of Human Embryonic Stem Cell Banks: Prospects for Tissue Matching
Lin, G., Ou-Yang, Q., Qian, X., & Lu, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5480-9_7 · Cited by 4
“Although some researchers have reported that hES cells and the derived cells or tissues express low levels of HLA molecules [2, 3] and have unique immune-privileged characteristics [27–29], they can express high levels of HLA under certain conditions and therefore allogeneic transplantation with these cells will still…”
ResultHollander, A. P., & Wraith, D. C. (2008) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848161832_0010 · Cited by 3
STEM CELL RESEARCH: FUTURE IMPLICATIONS FOR INTERNAL MEDICINE
Verfaillie, C. M. (2005) · Acta Clinica Belgica · doi:10.1179/acb.2005.045 · Cited by 3
Differentiation status determines tumorigenicity and immunogenicity of cancer cellsPreprint
Liu, Y., Wang, C., Li, H., & Cao, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.30.656250 · Cited by 3
Shroff, G., Srivastav, A., & Shroff, R. (2018) · International Journal of Stem Cells · doi:10.15283/ijsc17064 · Cited by 2
Engineering of the immune system for human ESC- and iPSC-derived grafts
Tso, G. H. W., He, J., & Chan, C. W. Y. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.09.002 · Cited by 2
Cellular Therapy in Thoracic and Cardiovascular Disease
Menasché, P. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.08.044 · Cited by 2
Ricklefs, F. L., & Schrepfer, S. (2012) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-4666-2506-8.ch005 · Cited by 2
Human embryonic stem cells (hESC) as a source of insulin-producing cells
Sackett, S. D., Tremmel, D. M., Feeney, A. K., Mitchell, S. A., & Odorico, J. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00027-0 · Cited by 3
Barbarisi, A. (2010) · Springer eBooks · doi:10.1007/978-88-470-1658-3 · Cited by 2
Immune Modulation for Stem Cell Therapy
Faleo, G., & Tang, Q. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-322-6_18 · Cited by 2
Catalucci, D., Bang, M., & Condorelli, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707633 · Cited by 2
“A promising new strategy to counter this loss is the use of cell-based therapies by engraftment of functional cardiac myocytes and thus to restore full contractility to the damaged tissue (Hassink et al., 2004).”
BackgroundCao, Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1843646 · Cited by 1
“…named Immune privileged (Hori et al., 2003; Itakura et al., 2017; Ozaki et al., 2017) Immune privileged Immune privileged (Fändrich et al., 2002; Drukker et al., 2006; Magliocca et al., 2006) Defined by ancestral regulatory networks (Xu et al., 2021; Domazet-Loso et al., 2007) Dependent on…”
Generation of Definitive Engraftable Hematopoietic Stem Cells from Human Pluripotent Stem Cells
Daheron, L. M., & Scadden, D. T. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch3 · Cited by 2
Cell Transplantation: A Possible Alternative to Orthotopic Liver Transplant (OLT)
Skvorak, K. J., Gramignoli, R., Hansel, M. C., Uraz, S., Tahan, V., Dorko, K., Marongiu, F., & Strom, S. C. (2012) · InTech eBooks · doi:10.5772/29903 · Cited by 1
“, 2004), and almost undetectable levels of HLA class II antigens and co-stimulatory factors (Drukker et al., 2006).”
BackgroundStammzellforschung: Die Diskussionslage im Bereich der philosophischen Ethik
Wallner, J. (2008) · Springer eBooks · doi:10.1007/978-3-211-77512-7_9 · Cited by 1
Lee, J. E., Kang, M. S., & Lee, D. R. (2012) · Springer eBooks · doi:10.1007/978-94-007-2993-3_4 · Cited by 1
Skin and corneal cellular therapy using embryonic stem cells: how far are we?
Shalom‐Feuerstein, R., & Aberdam, D. (2008) · Expert Review of Dermatology · doi:10.1586/17469872.3.3.357 · Cited by 1
Cardiac recovery by stem and progenitor cells
Laake, L. W. V. (2009) · Netherlands Heart Journal · doi:10.1007/bf03086258 · Cited by 1
Immunobiology of Embryonic and Induced Pluripotent Stem Cell Transplantation
Bolton, E. M., Bradley, J. A., & Taylor, C. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_6 · Cited by 1
Tieng, C. D. R. V. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s6-006 · Cited by 1
“Seminal publications strongly suggest that pluripotent cells, such as hES cells possess immune-privileged properties [1-3].”
Genetic Approaches in Human Embryonic Stem Cells and Their Derivatives
Ji, J., Zhong, B., & Bhatia, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012369410-2.50013-9 · Cited by 2
Zhang, C., Liao, W., Cai, B., Liu, F., Ke, Q., Zhu, X., He, X., & Hu, A. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0712-1 · Cited by 1
“According to recent findings, the immune privilege of ESCs and differentiated cells derived from ESCs might be related to the different epigenetic control of major histocompatibility and antigen processing molecules [24, 25].”
Khan, I. N., Ramadan, W. S., Abdel-Hamid, G. A., Karim, S. A. M., & Aurangzeb, H. (2018) · InTech eBooks · doi:10.5772/intechopen.73220 · Cited by 1
“Nonetheless, cellular transplantation therapies for SCIs are becoming more exciting and interesting, especially when research studies of lower immune rejections and preventing teratoma formation are paving the ways for future regenerative research [126, 148].”
BackgroundArán, B., Raya, Á., & Veiga, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_14 · Cited by 1
Transplantation Immunology: Retinal Cell-Based Therapy
Sandhu, H. S., Adeniran, J. F., & Kaplan, H. J. (2019) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-05222-5_8 · Cited by 1
Genetic Approaches in Human Embryonic Stem Cells and their Derivatives
Ji, J., Zhong, B., & Bhatia, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00025-1 · Cited by 1
The Immune Response and Implications for Nerve Repair
Roberton, V. H. (2021) · Reference series in biomedical engineering · doi:10.1007/978-3-030-06217-0_15-1 · Cited by 1
Eiges, R., Zak, N. B., Reubinoff, B. E., & Irving, C. S. (2015) · Wiley eBooks · doi:10.1002/9781118846193.ch25 · Cited by 1
Neroeva, N. V., Balatskaya, N. V., Brilliantova, A. G., Катаргина, Л. А., Kharitonov, A. E., Lagarkova, M. A., & Bogomazova, A. N. (2024) · Ophthalmology in Russia · doi:10.18008/1816-5095-2024-1-193-204 · Cited by 1
Wu, Q., Xi, J., Li, Y., & Pei, X. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00474 · Cited by 1
Current trends in type 1 diabetes mellitus--stem cells and beyond.
Hingorjo, M. R., Syed, S., Qureshi, M. A., & Kumar, A. (2007) · PubMed · Cited by 1
Krylov, I. A. (1977) · PubMed · Cited by 1
Jenkins, M. J. (2018) · UCL Discovery (University College London) · Cited by 1
Ingénierie tissulaire des ligaments : conception d'un bioréacteur et étude des propriétés mécaniques
Kahn, C. J. F. (2009) · theses.fr (ABES) · doi:10.70675/15c5b306z44a1z4ceaza197zb8a0151b56ef · Cited by 4
Myocardial Repair and Restoration
Wong, S. S. Y., & Bernstein, H. S. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-322-6_9
Cervera, R. P., & Stojković, M. (2013) · Wiley eBooks · doi:10.1002/9783527669417.ch2
Sidney, L. E. (2013) · Nottingham ePrints (University of Nottingham)
Embryonic Stem Cells, Cardiomyoplasty, and the Risk of Teratoma Formation
Šarić, T., Frenzel, L. P., Fatima, A., Gupta, M. K., & Hescheler, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-905-5_14
Human embryonic stem cells (hESCs) for heart regeneration
Menasché, P. (2014) · Elsevier eBooks · doi:10.1533/9780857096708.3.266
Medizinische Perspektiven der kardilen Stammzellforschung
Halbach, M., Reppel, M., Pillekamp, F., Müller‐Ehmsen, J., & Hescheler, J. (2008) · Springer eBooks · doi:10.1007/978-3-540-69414-4_19
Ji, J., Zhong, B., & Bhatia, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10009-4
One Successful Series Begets Another
Rao, M. S. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0549
Embryonic Stem Cell Research: A Question of Beliefs?
Maier, B. B., & Shibles†, W. A. (2010) · International library of ethics, law, and the new medicine/The international library of ethics, law, and the new medicine · doi:10.1007/978-90-481-8867-3_15
Daniels, R., & Roberts, G. (2006) · Asia-Pacific Biotech News · doi:10.1142/s0219030306000504
The prospect of pluripotent stem cell-based therapy
Borisenko, G. G. (2009) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750809030044
Lebedinsky, A. S., Cherkashina, D. V., An, S., Волкова, Н. А., Fuller, B. J., & Petrenko, O. (2007) · Cryobiology · doi:10.1016/j.cryobiol.2007.05.005
In Vitro hESC Technology: State of the Art and Future Perspectives
Rust, W. L. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8274-0_9
Human Embryonic Stem Cells; A novel model system for early human development
Gertow, K. (2006) · Figshare
Regenerative Medicine: Current and Potential Applications
Barbarisi, A., & Rosso, F. (2010) · Springer eBooks · doi:10.1007/978-88-470-1658-3_5
“An independent study using mice with a humanized d immune system confirmed a very low T-cell response to human ES cells and differentiated derivatives [ 40 ].”
MethodSafe Transplantation of Pluripotent Stem Cell by Preventing Teratoma
Hamidieh, A. A., Verdi, J., & Shoae‐Hassani, A. (2014)
Generation of Histocompatible Tissues via Parthenogenesis
Lampton, P. W., Newmark, J. A., & Kiessling, A. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5480-9_8
The current knowledge of immune privilege in stem cells
Li, Y. (2014) · Journal of Transplantation & Stem Cell Biology · doi:10.13188/2374-9326.1000002
“Indeed, several reports have shown that both mouse and human embryonic SCs can avoid immune rejection, and mouse embryonic SCs can survive in immunocompetent mice, rats, and sheep for weeks [52-56].”
BackgroundiPS Cell-Derived Immunosuppressive Myeloid Cells
Zavazava, N. (2015) · Transplantation · doi:10.1097/tp.0000000000000876
COMPONENT SCREENING FOR NOVEL XENOFREE MEDIUM FOR HUMAN EMBRYONIC STEM CELLS
Tuomisto, S. (2007) · Jyväskylä University Digital Archive (University of Jyväskylä)
New Horizons in Pediatric Hepatology: A Glimpse of the Future
Fitzpatrick, E., & Dhawan, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_75
Galla, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5699
Chen‐Konak, L., Fine, A., & Levenberg, S. (2011) · Biotechnology and bioprocessing series · doi:10.1201/b11285-3
Suppression of HLA Expression by Lentivirus-Mediated Gene Transfer of siRNA Cassettes
Kasahara, N. (2008) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949814_0006
Immunological barriers to regenerative medicine: do they matter?
Trento, C., & Dazzi, F. (2015) · Wiley eBooks · doi:10.1002/9781118846193.ch27
The major histocompatibility complex in mouse embryos and embryonic stem cells
Lampton, P. W. (2008) · Digital Repository Service (Northeastern University) · doi:10.17760/d10016867
KETOLA, S. (2006) · Tampere University Institutional Repository (Tampere University)
Johannsen, H. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6211
CTLCells from Lysis by Antigen-Specific Serpin-6 Expression Protects Embryonic
Hescheler, J., Yazdanpanah, B., Fleischmann, B. K., Abdullah, Z., Šarić, T., & Kashkar, H. (2013)
New brawn, old brain: head transplant.
JAMES, M. R. (2018) · doi:10.35841/neuroscience.1.1.17-18
McQuaig, R. C. Y. (2018) · Otago University Research Archive (University of Otago)
Engraftment and tolerance induction in cellular therapy : focus on mesenchymal stromal cells
Ljung, K. (2018) · Figshare
Histogenesis Stages of Osteogenic Grafts in Culture Medium and a Recipient Bed
Zaydman, A. M., Шевченко, Ю. А., Strokova, E. L., Gusev, A. F., Pakhomova, N. Y., Kirilova, I. A., Рерих, В. В., & Subbotin, V. M. (2019) · Cell and Tissue Biology · doi:10.1134/s1990519x19050109
Furth, M. E., & Atala, A. (2007) · Elsevier eBooks · doi:10.1016/b978-012370615-7/50008-1
이유진, & Kim, H.-K. (2009) · Tissue Engineering and Regenerative Medicine
Strategies for Myocardial Tissue Engineering: The Beat Goes On
Akhyari, P., Barth, M., Aubin, H., & Lichtenberg, A. (2011) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/8415_2011_90
Use of Regenerative Tissue for Urinary Diversion
Sopko, N. A., Kates, M. R., Singh, A., Steinberg, G. D., Smith, N. D., Schoenberg, M., & Bivalacqua, T. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-52186-2_7
Hypoproliferative human NPC xenografts survived extendedly in the brain of immunocompetent ratsPreprint
Liu, C., Wang, X., Huang, W., Meng, W., Su, Z., Xing, Q., Shi, H., Zhang, D., Zhou, M., Zhao, Y., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-92873/v1
Islet Cell Therapy and Pancreatic Stem Cells
Domínguez-Bendala, J., Pileggi, A., & Ricordi, C. (2008) · Elsevier eBooks · doi:10.1016/b978-012369410-2.50024-3
The Immune Response and Implications for Nerve Repair
Roberton, V. H. (2022) · Reference series in biomedical engineering · doi:10.1007/978-3-030-21052-6_15
Neural Induction: the General Principle for Embryogenesis and TumorigenesisPreprint
Cao, Y. (2022) · Preprints.org · doi:10.20944/preprints202208.0203.v1
Stem cell-based organoid cultures as innovative approaches for ocular repair and regeneration
Nasonkin, I. O., & Rizzolo, L. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99987-8.00005-9
New Avenues of Delivery (Subretinal Gene Therapy, Port Delivery, Suprachoroidal)
Nair, A. A., Chaili, S., & Law, J. C. (2023) · Current practices in ophthalmology · doi:10.1007/978-981-99-1661-0_19
Entwicklung von Stammzellen in der kardio-regenerativen Therapie
Fakoya, A. O. J., Fenemigho, I., Asuzu, C. V., Ukponmwan, E. E., Nnawuba, K. C., & Haider, K. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-25378-2_7
Grosembacher, L., Pereyra-Bonnet, F., Muratore, C., Pomares, M. L., Avila, P., Retamosa, J., Cuzziol, G. E., Maldini, A. C., Marco, R. D., Apoloni, S. B., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v49i3.635
“Las SCE demostraron prevenir la activación inmune en respuesta a las células presentadoras de antígenos in vitro y tienen la capacidad de promover la supervivencia del aloinjerto in vivo 112,113 .”
BackgroundWeiser, J. (2024) · Springer eBooks · doi:10.1007/978-3-031-59750-3_2
Weiler‐Sagie, M., & Gepstein, L. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-021-8_5
“Moreover, with use of the human/mouse trimera model (enabling the assessment of the direct alloimmune response of the human immune system to transplanted human cells), it was demonstrated that transplanted hESCs elicit only a relatively small immune response [39].”
MethodLiu, C., Wang, X., Huang, W., Meng, W., Su, Z., Xing, Q., Shi, H., Zhang, D., Zhou, M., Zhao, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14904081
Etude de l’immunogénicité des progéniteurs cardiaques dérivés des cellules souches embryonnaires
Calderon, D. (2013) · theses.fr (ABES) · doi:10.70675/470b40b8zcc23z4d48za193z4205e06cc8f4
Harane, N. E. (2018) · theses.fr (ABES) · doi:10.70675/77a82219z9a7fz448bzaa34z92eecbd3dfa9
Metadata
- Authors
- Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., & Benvenisty, N.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Weizmann Institute of Science (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
- Corresponding author
- Drukker, Micha
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-18
- Volume
- 24
- Issue
- 2
- Pages
- 221-229
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2006712783
- Cited by
- 402
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 16 · 2017: 15 · 2016: 12 · 2015: 21 · 2014: 19 · 2013: 30 · 2012: 34
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- human embryonic stem cells, immune rejection, xenotransplantation, allorejection, T cell response, cytotoxic T lymphocytes, MHC class I, immunodeficient mice, immunocompetent mice, cell therapy, immunosuppression
- MeSH terms
- Animals, Cell Differentiation, Embryo, Mammalian, Graft Rejection, Humans, Immunocompetence, Membrane Glycoproteins, Mice, Inbred Strains, Mice, Mutant Strains, Stem Cells, T-Lymphocytes, Cytotoxic, Transplantation, Heterologous, T-Lymphocyte Subsets, Mice, SCID, Gene Expression Profiling, Stem Cell Transplantation, Tumor Necrosis Factors, Mice, Fas Ligand Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.